Late onset ureteric obstruction after endoscopic subureteric injection of calcium hydroxyapatite for primary vesicoureteric reflux

Urology. 2007 Oct;70(4):811.e1-3. doi: 10.1016/j.urology.2007.07.033.

Abstract

Ureteric obstruction occurs in about 1% of cases undergoing endoscopic treatment of vesicoureteric reflux (VUR). It usually develops shortly after treatment. We report on a case of obstruction occurring 1 year after subureteric injection of calcium hydroxyapatite. Obstruction was progressive and eventually required open ureteric reimplantation. Ureteric obstruction can occur also in the long-term after endoscopic treatment of VUR and even in the absence of symptoms. Although it is so rare as to make long-term follow-up of all treated cases cost ineffective, physicians should be aware of such complications, especially while testing new bulking agents.

Publication types

  • Case Reports

MeSH terms

  • Biocompatible Materials / administration & dosage*
  • Biocompatible Materials / adverse effects
  • Child, Preschool
  • Cystoscopy*
  • Durapatite / administration & dosage*
  • Durapatite / adverse effects
  • Female
  • Humans
  • Injections / adverse effects
  • Prostheses and Implants / adverse effects*
  • Ureter
  • Ureteral Obstruction / etiology*
  • Vesico-Ureteral Reflux / therapy*

Substances

  • Biocompatible Materials
  • Durapatite